Anton Pottegård

Medicine & Life Sciences

1. Denmark 100%
2. Drug Utilization 69%
3. Prescriptions 60%
4. Cohort Studies 55%
5. Pharmaceutical Preparations 52%
6. Case-Control Studies 46%
7. Registries 42%
8. Confidence Intervals 42%
9. Odds Ratio 38%
10. Population 31%
11. Hydroxymethylglutaryl-CoA Reductase Inhibitors 27%
12. Anticoagulants 26%
13. Deprescriptions 24%
14. Vitamin K 24%
15. Prescription Drugs 23%
16. Warfarin 23%
17. Hydrochlorothiazide 21%
18. Skin Neoplasms 20%
19. Databases 19%
20. Scandinavian and Nordic Countries 18%
21. Atrial Fibrillation 18%
22. Proton Pump Inhibitors 17%
23. Therapeutics 17%
24. Systematic Reviews 17%
25. Mortality 16%
26. Delivery of Health Care 16%
27. Adrenal Cortex Hormones 15%
28. phthalic acid 15%
29. Severe Acute Respiratory Syndrome 14%
30. SARS Virus 14%
31. International Normalized Ratio 14%
32. Child 13%
33. Coronavirus 13%
34. Neoplasms 13%
35. Sweden 13%
36. Propensity Score 13%
37. Anti-Inflammatory Agents 12%
38. Norway 12%
39. Incidence 12%
40. Melanoma 12%
41. Hemorrhage 12%
42. Aspirin 11%
43. Pharmacists 11%
44. Health 11%
45. Attention Deficit Disorder with Hyperactivity 11%
46. Pharmacoepidemiology 11%
47. Life Expectancy 11%
48. Drug Interactions 11%
49. Antidepressive Agents 10%
50. Comorbidity 10%